SRT Therapeutics
PrivateLast Round
Seed
Aug 1, 2025
Total Funding Raised
$47.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SRT Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in August 2025.
SRT Therapeutics is a biotechnology company that develops precision medicine therapies targeting inflammatory pathways and tissue healing for inflammatory bowel disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SRT Therapeutics Comparables
Compare SRT Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radionetics Oncology | 86% | |
| Abdera Therapeutics | 85% | |
| Alpha-9 Oncology | 84% |
For institutional investors. Book with your work email.
SRT Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 20, 3.2x the trailing average.
- Sep 24, 2026
Grew 16% QoQ, from 25 to 29 employees.
For institutional investors. Book with your work email.
SRT Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SRT Therapeutics's valuation, stock price, and market status.
Is SRT Therapeutics a public or private company?
SRT Therapeutics is a private company.
What is the current stock price of SRT Therapeutics?
SRT Therapeutics is a private company, so its shares have no public market price. Caplight tracks SRT Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SRT Therapeutics worth (valuation)?
Valuation information for SRT Therapeutics is not publicly available.
Can I buy SRT Therapeutics stock?
SRT Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SRT Therapeutics's last funding round?
SRT Therapeutics's most recent funding round was Seed on August 1, 2025.
Who are the main investors in SRT Therapeutics?
Investor information for SRT Therapeutics is not publicly disclosed.
Will SRT Therapeutics IPO soon?
No public IPO plans have been announced for SRT Therapeutics.
How can I track SRT Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SRT Therapeutics's shares on secondary markets.